2001
DOI: 10.3109/02699200109167638
|View full text |Cite
|
Sign up to set email alerts
|

A preliminary study of the effects of sub thalamic nucleus (STN) deep brain stimulation (DBS) on voice and speech characteristics in Parkinson's Disease (PD)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
16
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(19 citation statements)
references
References 5 publications
3
16
0
Order By: Relevance
“…This study, therefore, corroborates the findings of previous studies reporting treatment outcomes of STN-DBS in terms of reducing the monopitch quality of PD patients' speech (Alatri et al, 2008;Dromey et al, 2000;Gentil et al, 2001;Hoffman-Ruddy et al, 2001). For cZi-DBS, no such positive effect on pitch variability was observed in our data.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…This study, therefore, corroborates the findings of previous studies reporting treatment outcomes of STN-DBS in terms of reducing the monopitch quality of PD patients' speech (Alatri et al, 2008;Dromey et al, 2000;Gentil et al, 2001;Hoffman-Ruddy et al, 2001). For cZi-DBS, no such positive effect on pitch variability was observed in our data.…”
Section: Discussionsupporting
confidence: 92%
“…Improvements have been observed in overall voice quality in terms of acoustic harmonic-to noise ratios (Van Lancker Sidtis, Rogers, Godier, Tagliati, & Sidtis, 2010), pitch range and voice stability (Alatri et al, 2008;Dromey, Kumar, Lang, & Lozano, 2000;Gentil, Chauvin, Pinto, Pollak, & Benabid, 2001;Hoffman-Ruddy, Schulz, Vitek, & Evatt, 2001). …”
Section: Introductionmentioning
confidence: 99%
“…De Letter, Santens, De Bodt et al (2007) reported improved respiratory measures following levodopa administration in all of 25 PD subjects tested. A single case study reported improved respiration and phonation time in DBS on (Hoffman-Ruddy et al, 2001) and longer phonation time was seen in a group of seven DBS patients (Rousseaux, Krystkowiak, Kozlowski, et al, 2004). Levodopa was observed to upscale the overall levels of vocal amplitude and tempo (Ho et al, 2008), presumably benefiting from enhanced respiratory function.…”
Section: Discussionmentioning
confidence: 98%
“…DBS treatment involves using a unilateral or bilateral stimulator to target electrical signals to the STN, which is believed to disrupt brain signaling responsible for the motor and vocal impairment symptoms of PD. [1,10,11] DBS has been shown to alleviate motor symptoms, but its effects on voice are less clear. [1214] Recent studies focusing on the use of levodopa in conjunction with DBS of the STN have argued that DBS of the STN affects neuronal structures involved in voice that are not affected by levodopa, namely non-dopaminergic lesions.…”
Section: Introductionmentioning
confidence: 99%
“…[5,16] These studies have applied acoustic perturbation analysis to evaluate the effects of DBS and levodopa. [11,18,19]…”
Section: Introductionmentioning
confidence: 99%